In total, we identified 11 normal- and 69 CML-specific doublets from the co-expression structures, which include 6 and 21 NPM1-doublets respectively (Fig. 3). The gene discussed is NPM1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.